US Stock MarketDetailed Quotes

CURATIVE BIOSCIENCES INC (CBDX)

Watchlist
  • 0.000100
  • 0.0000000.00%
15min DelayClose Apr 7 15:31 ET
3.16KMarket Cap0.00P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CURATIVE BIOSCIENCES INC (CBDX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2018
(Q2)Dec 31, 2017
(Q1)Sep 30, 2017
(FY)Jun 30, 2017
(Q4)Jun 30, 2017
(Q3)Mar 31, 2017
(Q2)Dec 31, 2016
(Q1)Sep 30, 2016
(FY)Jun 30, 2016
(Q4)Jun 30, 2016
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
699.55%31.98K
6,547.79%451.52K
-31.86%16.7K
-96.79%53.2K
-71.12%17.89K
-24.85%4K
-99.38%6.79K
-94.99%24.51K
-2.84%1.66M
-33.48%61.96K
Selling and administrative expenses
535.77%20.9K
7,295.59%449.65K
-34.04%15.7K
-96.76%53.2K
-79.55%20.03K
-28.69%3.29K
-99.45%6.08K
-94.58%23.8K
-3.78%1.64M
1.49%97.97K
-General and administrative expense
535.77%20.9K
7,295.59%449.65K
----
-96.76%53.2K
--20.03K
--3.29K
--6.08K
----
--1.64M
----
Research and development costs
--10.61K
--1.15K
--293
----
----
--0
--0
--0
----
----
Depreciation amortization depletion
-33.71%472
0.00%712
0.00%712
----
----
0.00%712
0.00%712
0.00%712
----
----
-Depreciation and amortization
-33.71%472
0.00%712
0.00%712
----
----
0.00%712
0.00%712
0.00%712
----
----
Other operating expenses
----
----
----
----
----
----
----
----
--16.13K
----
Operating profit
-699.55%-31.98K
-6,547.79%-451.52K
31.86%-16.7K
96.79%-53.2K
71.12%-17.89K
24.85%-4K
99.38%-6.79K
94.99%-24.51K
2.84%-1.66M
33.48%-61.96K
Net non-operating interest income expense
Other net income (expense)
Income before tax
-699.55%-31.98K
-6,547.79%-451.52K
31.86%-16.7K
96.79%-53.2K
60.96%-17.89K
24.85%-4K
-100.62%-6.79K
95.15%-24.51K
50.80%-1.66M
84.41%-45.83K
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
-699.55%-31.98K
-6,547.79%-451.52K
31.86%-16.7K
96.79%-53.2K
60.96%-17.89K
24.85%-4K
-100.62%-6.79K
95.15%-24.51K
50.80%-1.66M
84.41%-45.83K
Net income continuous Operations
-699.55%-31.98K
-6,547.79%-451.52K
31.86%-16.7K
96.79%-53.2K
60.96%-17.89K
24.85%-4K
-100.62%-6.79K
95.15%-24.51K
50.80%-1.66M
84.41%-45.83K
Minority interest income
Net income attributable to the parent company
-699.55%-31.98K
-6,547.79%-451.52K
31.86%-16.7K
96.79%-53.2K
60.96%-17.89K
24.85%-4K
-100.62%-6.79K
95.15%-24.51K
50.80%-1.66M
84.41%-45.83K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-699.55%-31.98K
-6,547.79%-451.52K
31.86%-16.7K
96.79%-53.2K
60.96%-17.89K
24.85%-4K
-100.62%-6.79K
95.15%-24.51K
50.80%-1.66M
84.41%-45.83K
Basic earnings per share
-540.78%-0.0016
-6,844.44%-0.03
32.03%-0.0011
97.18%-0.0034
-0.0011
25.44%-0.0003
-100.54%-0.0004
96.09%-0.0016
72.73%-0.12
0
Diluted earnings per share
-540.78%-0.0016
-6,844.44%-0.03
32.03%-0.0011
97.18%-0.0034
-0.0011
25.44%-0.0003
-100.54%-0.0004
96.09%-0.0016
72.73%-0.12
0
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Mar 31, 2018(Q2)Dec 31, 2017(Q1)Sep 30, 2017(FY)Jun 30, 2017(Q4)Jun 30, 2017(Q3)Mar 31, 2017(Q2)Dec 31, 2016(Q1)Sep 30, 2016(FY)Jun 30, 2016(Q4)Jun 30, 2016
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 699.55%31.98K6,547.79%451.52K-31.86%16.7K-96.79%53.2K-71.12%17.89K-24.85%4K-99.38%6.79K-94.99%24.51K-2.84%1.66M-33.48%61.96K
Selling and administrative expenses 535.77%20.9K7,295.59%449.65K-34.04%15.7K-96.76%53.2K-79.55%20.03K-28.69%3.29K-99.45%6.08K-94.58%23.8K-3.78%1.64M1.49%97.97K
-General and administrative expense 535.77%20.9K7,295.59%449.65K-----96.76%53.2K--20.03K--3.29K--6.08K------1.64M----
Research and development costs --10.61K--1.15K--293----------0--0--0--------
Depreciation amortization depletion -33.71%4720.00%7120.00%712--------0.00%7120.00%7120.00%712--------
-Depreciation and amortization -33.71%4720.00%7120.00%712--------0.00%7120.00%7120.00%712--------
Other operating expenses ----------------------------------16.13K----
Operating profit -699.55%-31.98K-6,547.79%-451.52K31.86%-16.7K96.79%-53.2K71.12%-17.89K24.85%-4K99.38%-6.79K94.99%-24.51K2.84%-1.66M33.48%-61.96K
Net non-operating interest income expense
Other net income (expense)
Income before tax -699.55%-31.98K-6,547.79%-451.52K31.86%-16.7K96.79%-53.2K60.96%-17.89K24.85%-4K-100.62%-6.79K95.15%-24.51K50.80%-1.66M84.41%-45.83K
Income tax 0000000000
Net income -699.55%-31.98K-6,547.79%-451.52K31.86%-16.7K96.79%-53.2K60.96%-17.89K24.85%-4K-100.62%-6.79K95.15%-24.51K50.80%-1.66M84.41%-45.83K
Net income continuous Operations -699.55%-31.98K-6,547.79%-451.52K31.86%-16.7K96.79%-53.2K60.96%-17.89K24.85%-4K-100.62%-6.79K95.15%-24.51K50.80%-1.66M84.41%-45.83K
Minority interest income
Net income attributable to the parent company -699.55%-31.98K-6,547.79%-451.52K31.86%-16.7K96.79%-53.2K60.96%-17.89K24.85%-4K-100.62%-6.79K95.15%-24.51K50.80%-1.66M84.41%-45.83K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -699.55%-31.98K-6,547.79%-451.52K31.86%-16.7K96.79%-53.2K60.96%-17.89K24.85%-4K-100.62%-6.79K95.15%-24.51K50.80%-1.66M84.41%-45.83K
Basic earnings per share -540.78%-0.0016-6,844.44%-0.0332.03%-0.001197.18%-0.0034-0.001125.44%-0.0003-100.54%-0.000496.09%-0.001672.73%-0.120
Diluted earnings per share -540.78%-0.0016-6,844.44%-0.0332.03%-0.001197.18%-0.0034-0.001125.44%-0.0003-100.54%-0.000496.09%-0.001672.73%-0.120
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! Iran's foreign minister, in accordance with the Lebanon ceasefire agreement, announced Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -